Clin Endosc.  2025 Jan;58(1):1-9. 10.5946/ce.2024.023.

Role of endoscopy in eosinophilic esophagitis

• Yang EJ
• Jung KW

• KMID: 2564013
• DOI: http://doi.org/10.5946/ce.2024.023

Abstract

Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease involving inflammation of the esophagus. Endoscopy is essential in the diagnosis and treatment of EoE and shows typical findings, including esophageal edema, rings, exudates, furrows, and stenosis. However, studies involving pediatric and adult patients with EoE suggest that even a normally appearing esophagus can be diagnosed as EoE by endoscopic biopsy. Therefore, in patients with suspected EoE, biopsy samples should be obtained from the esophagus regardless of endoscopic appearance. Moreover, follow-up endoscopies with biopsy after therapy initiation are usually recommended to assess response. Although previous reports of endoscopic ultrasonography findings in patients with EoE have shown diffuse thickening of the esophageal wall, including lamina propria, submucosa, and muscularis propria, its role in EoE remains uncertain and requires further investigation. Endoscopic dilation or bougienage is a safe and effective procedure that can be used in combination with medical and/or dietary elimination therapy in patients with esophageal stricture for the management of dysphagia and to prevent its recurrence.

Keyword

Endoscopic dilation; Endoscopic ultrasonography; Endoscopy; Eosinophilic esophagitis

Figure

• 

  Fig. 1. Endoscopic view of eosinophilic esophagitis. (A) Mucosal edema. (B) Exudates. (C) Furrows. (D) Rings. (E) Stricture (arrowhead).

• 

  Fig. 2. Endoscopic ultrasonography findings in patients with eosinophilic esophagitis. (A, B) Diffuse thickening of the esophageal wall, including muscularis propria, is noted.

Reference

1. Muir A, Falk GW. Eosinophilic esophagitis: a review. JAMA. 2021; 326:1310–1318.

2. Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE Conference. Gastroenterology. 2018; 155:1022–1033.

3. Dellon ES. Eosinophilic esophagitis: what’s in a name? Dig Dis Sci. 2024; 69:330–334.

4. Dellon ES. Red between the lines: evolution of eosinophilic esophagitis as a distinct clinicopathologic syndrome. Dig Dis Sci. 2020; 65:3434–3447.

5. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007; 133:1342–1363.

6. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011; 128:3–20.

7. Molina-Infante J, Bredenoord AJ, Cheng E, et al. Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis. Gut. 2016; 65:524–531.

8. Dellon ES, Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology. 2018; 154:319–332.

9. Kim GH, Park YS, Jung KW, et al. An increasing trend of eosinophilic esophagitis in Korea and the clinical implication of the biomarkers to determine disease activity and treatment response in eosinophilic esophagitis. J Neurogastroenterol Motil. 2019; 25:525–533.

10. Kim GH, Jung KW, Jung HY, et al. Diagnostic trends and clinical characteristics of eosinophilic esophagitis: a Korean, single-center database study. J Neurogastroenterol Motil. 2018; 24:248–254.

11. Kim SJ, Park MI, Kim GH, et al. Practice patterns for eosinophilic esophagitis patients in Busan and Gyeongnam: a Korean multicenter database study. J Neurogastroenterol Motil. 2021; 27:71–77.

12. Kim GH, Park H, Jung KW, et al. Incidence, morbidity, and mortality of achalasia: a nationwide, population-based cohort study in South Korea. Gut Liver. 2023; 17:894–904.

13. Aceves SS, Alexander JA, Baron TH, et al. Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference. Gastrointest Endosc. 2022; 96:576–592.

14. Richter JE. Endoscopic treatment of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2018; 28:97–110.

15. Falk GW. Top tips for high-quality endoscopy in eosinophilic esophagitis. Gastrointest Endosc. 2023; 98:237–240.

16. Dhar A, Haboubi HN, Attwood SE, et al. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut. 2022; 71:1459–1487.

17. Gonsalves N, Policarpio-Nicolas M, Zhang Q, et al. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006; 64:313–319.

18. Saffari H, Peterson KA, Fang JC, et al. Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: implications for endoscopic biopsy. J Allergy Clin Immunol. 2012; 130:798–800.

19. Salek J, Clayton F, Vinson L, et al. Endoscopic appearance and location dictate diagnostic yield of biopsies in eosinophilic oesophagitis. Aliment Pharmacol Ther. 2015; 41:1288–1295.

20. Arias-González L, Rey-Iborra E, Ruiz-Ponce M, et al. Esophageal perforation in eosinophilic esophagitis: a systematic review on clinical presentation, management and outcomes. Dig Liver Dis. 2020; 52:245–252.

21. Hirano I, Furuta GT. Approaches and challenges to management of pediatric and adult patients with eosinophilic esophagitis. Gastroenterology. 2020; 158:840–851.

22. Hirano I, Moy N, Heckman MG, et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013; 62:489–495.

23. Dellon ES, Cotton CC, Gebhart JH, et al. Accuracy of the eosinophilic esophagitis endoscopic reference score in diagnosis and determining response to treatment. Clin Gastroenterol Hepatol. 2016; 14:31–39.

24. Wechsler JB, Bolton SM, Amsden K, et al. Eosinophilic esophagitis reference score accurately identifies disease activity and treatment effects in children. Clin Gastroenterol Hepatol. 2018; 16:1056–1063.

25. Kim HP, Vance RB, Shaheen NJ, et al. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol. 2012; 10:988–996.

26. Mackenzie SH, Go M, Chadwick B, et al. Eosinophilic oesophagitis in patients presenting with dysphagia: a prospective analysis. Aliment Pharmacol Ther. 2008; 28:1140–1146.

27. Murray IA, Joyce S, Palmer J, et al. Incidence and features of eosinophilic esophagitis in dysphagia: a prospective observational study. Scand J Gastroenterol. 2016; 51:257–262.

28. Ravi K, Talley NJ, Smyrk TC, et al. Low grade esophageal eosinophilia in adults: an unrecognized part of the spectrum of eosinophilic esophagitis? Dig Dis Sci. 2011; 56:1981–1986.

29. Gentile N, Katzka D, Ravi K, et al. Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther. 2014; 40:1333–1340.

30. Carlson DA, Shehata C, Gonsalves N, et al. Esophageal dysmotility is associated with disease severity in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2022; 20:1719–1728.

31. Dellon ES, Khoury P, Muir AB, et al. A clinical severity index for eosinophilic esophagitis: development, consensus, and future directions. Gastroenterology. 2022; 163:59–76.

32. O’Shea KM, Aceves SS, Dellon ES, et al. Pathophysiology of eosinophilic esophagitis. Gastroenterology. 2018; 154:333–345.

33. Chen J, Oshima T, Tomita T, et al. Regulatory T cells are increased and correlate with mast cells in eosinophilic esophagitis. J Neurogastroenterol Motil. 2024; 30:29–37.

34. Hirano I, Aceves SS. Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis. Gastroenterol Clin North Am. 2014; 43:297–316.

35. Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0^©. Neurogastroenterol Motil. 2021; 33:e14058.

36. Noh JH, Jung KW, Yoon IJ, et al. Comparison of diagnosis of esophageal motility disorders by Chicago classification versions 3.0 and 4.0. J Neurogastroenterol Motil. 2023; 29:326–334.

37. Cha B, Choi K, Jung KW, et al. High-resolution impedance manometry for comparing bolus transit between patients with non-obstructive dysphagia and asymptomatic controls. Neurogastroenterol Motil. 2023; 35:e14452.

38. Choi JY, Jung KW, Pandolfino JE, et al. Dysphagia associated with esophageal wall thickening in patients with nonspecific high-resolution manometry findings: understanding motility beyond the Chicago classification version 4.0. Neurogastroenterol Motil. 2024; 36:e14736.

39. Reddy SB, Ketchem CJ, Dougherty MK, et al. Association between eosinophilic esophagitis and esophageal dysmotility: a systematic review and meta-analysis. Neurogastroenterol Motil. 2023; 35:e14475.

40. Jung KW. The clinical usefulness of functional luminal imaging probe in esophageal dysmotility disorder. J Neurogastroenterol Motil. 2022; 28:509–511.

41. Moosavi S, Shehata C, Kou W, et al. Measuring esophageal compliance using functional lumen imaging probe to assess remodeling in eosinophilic esophagitis. Neurogastroenterol Motil. 2023; 35:e14525.

42. Carlson DA, Hirano I, Gonsalves N, et al. Composite score of physiomechanical esophageal function using functional lumen imaging probe panometry in eosinophilic esophagitis. Gastrointest Endosc. 2024; 99:499–510.

43. Araujo IK, Shehata C, Hirano I, et al. The severity of reduced esophageal distensibility parallels eosinophilic esophagitis disease duration. Clin Gastroenterol Hepatol. 2024; 22:513–522.

44. Wong S, Tippett M, Zobel J, et al. Distal esophageal wall thickness correlates with dysphagia in adult patients with eosinophilic esophagitis. Esophagus. 2022; 19:554–559.

45. Suzuki Y, Ochiai Y, Hosoi A, et al. Mucosal and submucosal thickening of esophageal wall is a promising factor in the development of symptoms in eosinophilic esophagitis. Gut Liver. 2024; 18:50–59.

46. Muroi K, Kakushima N, Furukawa K, et al. Subjective symptoms in patients with eosinophilic esophagitis are related to esophageal wall thickness and esophageal body pressure. Dig Dis Sci. 2021; 66:2291–2300.

47. Fox VL, Nurko S, Teitelbaum JE, et al. High-resolution EUS in children with eosinophilic “allergic” esophagitis. Gastrointest Endosc. 2003; 57:30–36.

48. Rabinowitz SS, Grossman E, Feng L, et al. Predicting pediatric esophageal wall thickness: an EUS study. Endosc Ultrasound. 2020; 9:259–266.

49. Visaggi P, Baiano Svizzero F, Savarino E. Food elimination diets in eosinophilic esophagitis: practical tips in current management and future directions. Best Pract Res Clin Gastroenterol. 2023; 62-63:101825.

50. Franciosi JP, Mougey EB, Dellon ES, et al. Proton pump inhibitor therapy for eosinophilic esophagitis: history, mechanisms, efficacy, and future directions. J Asthma Allergy. 2022; 15:281–302.

51. Alexander JA, Jung KW, Arora AS, et al. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012; 10:742–749.

52. Cotton CC, Eluri S, Wolf WA, et al. Six-food elimination diet and topical steroids are effective for eosinophilic esophagitis: a meta-regression. Dig Dis Sci. 2017; 62:2408–2420.

53. Snyder DL, Dellon ES. Biologics in the treatment of eosinophilic esophagitis: ready for use? Clin Gastroenterol Hepatol. 2023; 21:3230–3233.

54. Kagalwalla AF, Wechsler JB, Amsden K, et al. Efficacy of a 4-food elimination diet for children with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2017; 15:1698–1707.

55. Nielsen JA, Lager DJ, Lewin M, et al. The optimal number of biopsy fragments to establish a morphologic diagnosis of eosinophilic esophagitis. Am J Gastroenterol. 2014; 109:515–520.

56. Jung KW, Gundersen N, Kopacova J, et al. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc. 2011; 73:15–21.

57. Kaplan M, Mutlu EA, Jakate S, et al. Endoscopy in eosinophilic esophagitis: “feline” esophagus and perforation risk. Clin Gastroenterol Hepatol. 2003; 1:433–437.

58. Hirano I. Dilation in eosinophilic esophagitis: to do or not to do? Gastrointest Endosc. 2010; 71:713–714.

59. Moawad FJ, Molina-Infante J, Lucendo AJ, et al. Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis. Aliment Pharmacol Ther. 2017; 46:96–105.

60. Schoepfer AM, Gonsalves N, Bussmann C, et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol. 2010; 105:1062–1070.

61. Kim JP, Weingart G, Hiramoto B, et al. Clinical outcomes of adults with eosinophilic esophagitis with severe stricture. Gastrointest Endosc. 2020; 92:44–53.

62. Runge TM, Eluri S, Woosley JT, et al. Control of inflammation decreases the need for subsequent esophageal dilation in patients with eosinophilic esophagitis. Dis Esophagus. 2017; 30:1–7.

63. Runge TM, Eluri S, Cotton CC, et al. Outcomes of esophageal dilation in eosinophilic esophagitis: safety, efficacy, and persistence of the fibrostenotic phenotype. Am J Gastroenterol. 2016; 111:206–213.

64. Lipka S, Keshishian J, Boyce HW, et al. The natural history of steroid-naïve eosinophilic esophagitis in adults treated with endoscopic dilation and proton pump inhibitor therapy over a mean duration of nearly 14 years. Gastrointest Endosc. 2014; 80:592–598.

65. Schoepfer AM, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013; 145:1230–1236.

66. Warners MJ, Oude Nijhuis RA, de Wijkerslooth LR, et al. The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort. Am J Gastroenterol. 2018; 113:836–844.

67. Schupack DA, Ravi K, Geno DM, et al. Effect of maintenance therapy for eosinophilic esophagitis on need for recurrent dilation. Dig Dis Sci. 2021; 66:503–510.

68. Dougherty M, Runge TM, Eluri S, et al. Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis. Gastrointest Endosc. 2017; 86:581–591.

69. Madanick RD, Shaheen NJ, Dellon ES. A novel balloon pull-through technique for esophageal dilation in eosinophilic esophagitis (with video). Gastrointest Endosc. 2011; 73:138–142.

70. Baron TH, Wong Kee Song LM, Zielinski MD, et al. A comprehensive approach to the management of acute endoscopic perforations (with videos). Gastrointest Endosc. 2012; 76:838–859.